Explore
Companies
Investors
Top 50
Streams
Trending tech news
Latest investments
Latest acquisitions
About Index
Index
By TNW
Log in
Register
Blueprint Medicines
4370
Blueprint Medicines
Health Care
Technology
Biotechnology
Blueprint Medicines discovers and develops highly selective kinase inhibitors for patients with genomically defined cancers
Suggest edits
Founded
2011
Raised
$240M
Follow us
Also headquartered in Cambridge
MIT
Raspberry Pi
ARM
Biogen
Xconomy
HubSpot
Money Mover
Formlabs
Akamai
General Catalyst
Companies in the same industry
Color
Akebia Therapeutics
PTC Therapeutics
Oncothyreon
Sentio Solutions Inc.
BrainStorm Cell Therapeutics
Morphogen-IX
Cariloop
RxAdvance
Valneva SE
Alexa global traffic share
Twitter followers
Overview
Funding
4
Add info
Add round
08 Dec
2016
$125,000,000
Post-IPO debt
Biotech Day on Twitter
Twitter
12 Nov
2014
$50,000,000
Venture capital (Series C)
Redmile Group
,
RA Capital Management
,
Wellington Management
,
+5
07 Jan
2014
$25,000,000
Venture capital (Series B)
Fidelity Biosciences
,
Third Rock Ventures
,
Casdin Capital
,
+2
11 Apr
2011
$40,000,000
Venture capital (Series A)
Fidelity Biosciences
,
Third Rock Ventures
